证券代码：871753 证券简称：天纺标 公告编号：2023-044 天纺标检测认证股份有限公司 2022 年年度报告业绩说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 说明会类型 天纺标检测认证股份有限公司（以下简称"公司"）于 2023 年 4 月 20 日在 北京证券交易所官方信息披露平台（http://www.bse.cn/)发布了《天纺标检测 认证股份有限公司 2022 年年度报告》（公告编号：2023-026），为方便广大投资 者更深入了解公司 2022 年年度经营业绩的具体情况，加强与投资者的互动交流， 公司拟召开 2022 年年度报告业绩说明会。 二、 说明会召开的时间、地点 （一）会议召开时间：2022 年 4 月 27 日 15:00-17:00。 （二）会议召开地点 本次业绩说明会将采用网络远程的方式举行，投资者可登录全景网"投资者 关系互动平台"（https://ir.p5w.net）参与。 三、 参加人员 公司董事长：葛传兵先生 公司总经理：吕刚先生 公司 ...

Company Overview - TianFangBiao successfully listed on the Beijing Stock Exchange on October 31, 2022, after receiving approval from the China Securities Regulatory Commission on September 27, 2022[5]. - The company established a subsidiary, TianFangBiao Biomedical (Tianjin) Co., Ltd., in November 2022 to further expand its life sciences segment[6]. - The company is recognized as a "High-tech Enterprise" and a "Tianjin Gazelle Enterprise" by the Tianjin Science and Technology Bureau[47]. - The company aims to become a leading domestic and internationally recognized comprehensive authority testing institution, focusing on intelligent testing laboratories and enhancing technological innovation capabilities[111]. Financial Performance - TianFangBiao's financial report for the year ending December 31, 2022, was audited and received a standard unqualified opinion from Zhongshun Hua Accounting Firm[14]. - The company's operating revenue for 2022 was CNY 142,633,060.05, a decrease of 8.54% compared to CNY 155,958,251.40 in 2021[34]. - The net profit attributable to shareholders for 2022 was CNY 33,030,410.94, down 10.61% from CNY 36,952,376.88 in 2021[34]. - The gross profit margin for 2022 was 53.98%, a decline from 58.45% in 2021[34]. - Total assets increased by 45.79% to CNY 449,892,218.65 at the end of 2022, compared to CNY 308,594,182.03 at the end of 2021[35]. - The company's net assets attributable to shareholders rose by 56.45% to CNY 407,596,217.18 in 2022, up from CNY 260,529,013.71 in 2021[35]. - The company reported a basic earnings per share of CNY 0.47 for 2022, a decrease of 12.96% from CNY 0.54 in 2021[34]. - The net cash flow from operating activities for 2022 was CNY 44,682,941.43, down 5.86% from CNY 47,462,344.61 in 2021[36]. Market and Competition - The company continues to face significant market competition from foreign third-party testing institutions entering the Chinese market[52]. - The inspection and testing service market in China reached a scale of CNY 358.592 billion in 2020, with a compound annual growth rate of 14.40% since 2013[106]. - The company is focused on expanding its testing capabilities across various sectors, including military-civilian integration and e-commerce platforms[112]. Risks and Challenges - The company faces risks related to internal control as it expands, necessitating adjustments in resource integration and market development[16]. - There is a notable risk of talent shortage and technology leakage in the testing industry, which could impact sustainable business development[16]. - Revenue recognition has been identified as a key audit matter due to the inherent risk of inappropriate revenue recognition to meet specific targets[99]. - The company acknowledges risks related to internal control as it expands, emphasizing the need for improved management and coordination among departments[117]. Research and Development - The company continues to leverage its expertise in quality inspection services, focusing on textiles, apparel, and related products, to enhance its market presence and authority[45]. - Research and development expenses rose by 9.90% to CNY 10.57 million, reflecting increased personnel costs and collaborative research expenses[59]. - The company has established a quality control plan that includes participation in capability verification and inter-laboratory comparisons to ensure high-quality testing operations[182]. - The company has a stable core technical team during the reporting period, ensuring continuity in expertise[178]. Corporate Governance - The company has established a modern corporate governance structure to improve management efficiency[132]. - The board consists of 9 members, including 3 independent directors, ensuring compliance with governance standards and protection of minority shareholders' rights[198]. - The company is committed to transparency and accountability in its financial reporting and decision-making processes[198]. - The company has established a comprehensive governance mechanism, ensuring protection and equal rights for all shareholders, particularly minority shareholders[187]. Shareholder and Stock Information - The largest shareholder, Tianjin Tianfang Investment Holding Co., Ltd., holds 48,902,903 shares, representing 60.07% of total shares[145]. - The company completed a public offering of 13,000,000 ordinary shares, increasing total share capital from 68,404,368 shares to 81,404,368 shares[142]. - The company has committed to stabilizing its stock price for three years post-IPO, initiating measures if the stock price falls below the audited net asset value per share for 20 consecutive trading days[130]. Future Plans and Strategies - The company plans to deepen its core business in textile testing and expand into food and environmental testing through mergers and acquisitions[114]. - The company will implement five key actions to enhance market development and customer maintenance, focusing on proactive service and customer relationship management[114]. - The company intends to enhance its capabilities in strategic emerging industries such as intelligent manufacturing and ecological protection, while developing the life sciences testing sector[114].

Financial Performance - The company's operating revenue for 2022 was CNY 142,633,060.05, a decrease of 8.54% compared to the previous year[3] - Net profit attributable to shareholders was CNY 33,132,341.76, down 10.34% year-on-year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 27,834,447.53, a decline of 18.48% compared to the previous year[3] - Basic earnings per share decreased to CNY 0.47, down 12.96% year-on-year[3] Assets and Equity - Total assets at the end of the reporting period reached CNY 450,071,827.00, an increase of 45.85% from the beginning of the year[4] - Shareholders' equity attributable to the company was CNY 407,698,148.00, up 56.49% year-on-year[4] - The total share capital increased to 81,404,368 shares, reflecting a growth of 19.00%[4] - The net asset value per share attributable to shareholders rose to CNY 5.01, a year-on-year increase of 31.50%[4] Impact Factors and Future Plans - The decline in revenue and profit was primarily due to the impact of the COVID-19 pandemic and a sluggish macroeconomic environment[6] - The company plans to enhance market expansion and technological innovation to drive growth as the pandemic's impact diminishes[7]